News
Skip Bayless thinks the WNBA might be lying about Caitlin Clark's injury. Clark, a two-time WNBA All-Star and the No. 1 ...
Endometrial cancer is hard to detect. Here are some signs of endometrial cancer worth bringing to your doctor's attention, ...
The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. | The ...
The test was developed in the University’s bio-incubator, the BioHub Birmingham, and the trials are the culmination of eight ...
Dosed first patient in SURF302 for intermediate risk non-muscle invasive bladder cancer (IR NMIBC) - - Cash, cash equivalents, and marketable securities of $296.3 ...
C utting edge technology developed with West Midlands “creativity, grit and passion” could transform cancer diagnostics and ...
Key Points GAAP loss per share of $(0.47) for Q2 2025 was narrower than the $(0.53) analysts had expected, despite an ongoing absence of revenue. Research and development expenses (GAAP) increased 35.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results